Display options
Share it on

Eur J Pediatr. 1992 Aug;151(8):601-7. doi: 10.1007/BF01957731.

Growth hormone treatment in children with preterminal chronic renal failure: no adverse effect on glomerular filtration rate.

European journal of pediatrics

B Tönshoff, C Tönshoff, O Mehls, J Pinkowski, W F Blum, U Heinrich, B Stöver, N Gretz

Affiliations

  1. Division of Paediatric Nephrology, University Children's Hospital, Heidelberg, Federal Republic of Germany.

PMID: 1380459 DOI: 10.1007/BF01957731

Abstract

Impaired growth and stunting remains a major therapeutic problem in children with chronic renal failure (CRF). Recombinant human growth hormone (rhGH) treatment may be beneficial, but concern has been raised about possible side-effects, i.e. deterioration of renal function and glucose intolerance. We have treated 10 prepubertal children with CRF (median age 7.5 [1.7-10.0] years) with 4 IU rhGH/m2 per day s.c. over a period of 1 year. Height velocity increased significantly (P less than 0.03) from basal 4.6 (2.0-14.0) cm/year to 9.7 (6.8-17.6) cm/year. Height velocity SDS for chronological age and for bone age increased in all children from basal median -2.3 to +3.8 (P less than 0.005). Median glomerular filtration rate (GFR) measured by single injection inulin clearance at onset was 18 (11-66) ml/min per 1.73 m2 and did not change significantly during the treatment year. The loss of GFR as estimated by creatinine clearance was similar during the treatment year (median loss 1.3 ml/min per 1.73 m2) compared to the year before treatment (median loss 3.7 ml/min per 1.73 m2). Serum glucose levels during an oral glucose tolerance test did not change, but fasting as well as stimulated insulin levels increased significantly with time during the study period. It is concluded that the rhGH regimen employed was remarkably effective in improving growth velocity in children with CRF without adversely affecting GFR. Glucose homeostasis remained stable, but at the expense of increased serum insulin levels.

Similar articles

Cited by

References

  1. Acta Endocrinol (Copenh). 1964 May;46:80-8 - PubMed
  2. N Engl J Med. 1986 Jul 24;315(4):220-4 - PubMed
  3. Metabolism. 1973 Feb;22(2):351-4 - PubMed
  4. Helv Paediatr Acta Suppl. 1989 Jun;52:1-125 - PubMed
  5. Lancet. 1991 Jan 12;337(8733):108-10 - PubMed
  6. J Clin Endocrinol Metab. 1990 May;70(5):1292-8 - PubMed
  7. Acta Endocrinol (Copenh). 1988 Jul;118(3):374-80 - PubMed
  8. Pediatrics. 1976 Aug;58(2):259-63 - PubMed
  9. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985;21:66-95 - PubMed
  10. J Clin Endocrinol Metab. 1988 Aug;67(2):353-60 - PubMed
  11. Metabolism. 1970 Feb;19(2):102-13 - PubMed
  12. Am J Physiol. 1985 Sep;249(3 Pt 2):F324-37 - PubMed
  13. Pediatr Nephrol. 1990 Nov;4(6):654-62 - PubMed
  14. Diabetes. 1982 Aug;31(8 Pt 1):663-9 - PubMed
  15. J Pediatr. 1989 Nov;115(5 Pt 1):758-61 - PubMed
  16. Acta Endocrinol (Copenh). 1978 Dec;89(4):796-800 - PubMed
  17. J Pediatr. 1989 Sep;115(3):365-71 - PubMed
  18. Hemoglobin. 1979;3(6):411-28 - PubMed
  19. J Clin Endocrinol Metab. 1989 Aug;69(2):253-8 - PubMed
  20. Pediatr Nephrol. 1991 Jul;5(4):496-500 - PubMed
  21. Clin Nephrol. 1989 Dec;32(6):266-9 - PubMed
  22. J Pediatr. 1990 Apr;116(4):561-6 - PubMed
  23. Am J Pathol. 1988 Jun;131(3):398-403 - PubMed
  24. Acta Paediatr Scand Suppl. 1990;367:137-41 - PubMed
  25. J Clin Endocrinol Metab. 1988 May;66(5):1075-9 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources